|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02427 GUANZE MEDICAL
Nominal 
2.650 +0.260 (+10.879%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 28,432 | -10.746% | 88,447 | 155,740 | 156,072 | 177,112 |
| Cost of Sales | (26,641) | 44.224% | (66,320) | (92,954) | (70,667) | (96,136) |
| Gross Profit | 1,791 | -86.617% | 22,127 | 62,786 | 85,405 | 80,976 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (5,071) | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (40,710) | -- | (31,378) | 26,309 | 38,650 | 29,962 | |
| Taxation | 1,582 | -- | 1,417 | (8,859) | (10,728) | (11,676) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 324 | -- | 245 | (246) | (355) | (342) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (38,804) | -- | (29,716) | 17,204 | 27,567 | 17,944 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 199 | -19.106% | 459 | (6) | 18 | 999 |
| Depreciation & Amortisation | 6,932 | 74.434% | 15,731 | 7,274 | 6,007 | 5,290 |
| Directors' Emoluments | -- | -- | -- | 2,588 | 2,080 | 313 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -4.100 | -- | -3.000 | 2.000 | 3.000 | 2.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 1.903 | 1.840 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 63.440% | 91.992% |
| Cash flow per share ($) | -- | -- | 0.011 | 0.023 | 0.009 | 0.012 |
| NBV per share ($) | 0.211 | -- | 0.244 | 0.273 | 0.284 | 0.274 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -38,804 |
| %Change | -- |
| EPS / (LPS) | RMB -0.041 |
| NBV Per Share (¥) | RMB 0.211 |